Analysts: Ads for BPH drugs don't help device makers

03/30/2008 | Pioneer Press (St. Paul, Minn.)

Television ads for drugs such as Flomax and Avodart that treat benign prostatic hyperplasia have resulted in either flat or reduced growth for device makers such as Medtronic, Urologix and American Medical Systems, analysts said. Effective drug advertising and the prevalence of hospital-based laser treatments appear to have altered the market for device treatments.

View Full Article in:

Pioneer Press (St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ